GET A VALUABLE CERTIFICATE FOR JOB MARKET


ACADEMIC RECOGNITION OF 3 OR 6 CREDITS


DESIGNED FOR EXPERTS BY EXPERTS


PRINCIPLES OF PHARMACOVIGILANCE


OBJECTIVES



To enable trainees to develop an understanding of the principles of pharmacovigilance from the development of the science to its place in pre and post-authorisation environment and the roles of various stakeholders within pharmacovigilance.

Introduction, regulations, legislation, principles

 

MODULE PARTS



  1. Introduction to pharmacovigilance principles.
  2. Safety evaluation during a products lifecycle.
  3. Labelling and risk management.

 

TRAINER TEAM



Coordinator: Dr Christopher Benham (from University of Hertfordshire)

Expert(s): Dr Sherael Webley (from University of Hertfordshire), Priya Bahri (from European Medicines Agency), John Talbot (from AstraZeneca AB), Wendy Brewster, Steve Hobbiger (from GlaxoSmithKline Research and Development Ltd), Dr David Lewis (from Novartis Pharma AG), Shelley Ghandi (from NDA Regulatory Science).

Introductory level
75 h workload over 3 months (3 ECTS credits)
Key dates
Course calendar
Certificate award
or included in Master Year 1 programme
English language
Online based learning
Student: 1,500 €
Professional: 3,000 €
  Savings could be offered under eligibility conditions.

Applications currently closed

Application to this training will be available
from January 29th, 2018 to September 09th, 2018.
Thanks for applying during this period.

Contact the Eu2P Central Office

Applications will open on January 29th, 2018. Please contact the Eu2P Central Office for information.

Or include this module in your training curriculum choices...

Master Year 1



Confused? Read the FAQs...

NEED TO TALK TO US?

+33 5 47 30 42 69

Monday-Friday / 9.00am-6.00pm CET

 

Supported By

IMI logo EU logo efpia logo

Created By

Eu2P Partners